Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
出版年份 2023 全文链接
标题
Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
作者
关键词
-
出版物
Nature Communications
Volume 14, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-01-13
DOI
10.1038/s41467-023-35815-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
- (2022) Wilfredo F. Garcia-Beltran et al. CELL
- Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
- (2022) Raquel Viana et al. NATURE
- Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants
- (2022) Hung Fu Tseng et al. NATURE MEDICINE
- SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
- (2022) Rolando Pajon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike
- (2022) Daichi Yamasoba et al. CELL
- Letter to the editor: Epidemiology of the SARS-CoV-2 variant Omicron BA.2 – vigilance needed
- (2022) Jing Huang et al. Eurosurveillance
- Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
- (2022) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization
- (2022) Daniel R. Feikin et al. VACCINE
- Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
- (2022) Hiam Chemaitelly et al. Nature Communications
- Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study
- (2022) Adam S Lauring et al. BMJ-British Medical Journal
- Durability of BNT162b2 vaccine against hospital and emergency department admissions due to the omicron and delta variants in a large health system in the USA: a test-negative case–control study
- (2022) Sara Y Tartof et al. Lancet Respiratory Medicine
- Seroprevalence of Infection-Induced SARS-CoV-2 Antibodies — United States, September 2021–February 2022
- (2022) Kristie E.N. Clarke et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
- (2022) Aekkachai Tuekprakhon et al. CELL
- Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5
- (2022) Qian Wang et al. NATURE
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa
- (2022) Houriiyah Tegally et al. NATURE MEDICINE
- Neutralization of the SARS-CoV-2 Omicron BA.4/5 and BA.2.12.1 Subvariants
- (2022) Panke Qu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5
- (2022) Nicole P. Hachmann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
- (2022) Khadija Khan et al. Nature Communications
- Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022
- (2022) Ruth Link-Gelles et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Long-term Protection Associated With COVID-19 Vaccination and Prior Infection
- (2022) Mark W. Tenforde et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- BNT162b2 vaccine effectiveness against SARS-CoV-2 omicron BA.4 and BA.5
- (2022) Sara Y Tartof et al. LANCET INFECTIOUS DISEASES
- Durability of Booster mRNA Vaccine against SARS-CoV-2 BA.2.12.1, BA.4, and BA.5 Subvariants
- (2022) Panke Qu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants
- (2022) João Malato et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of COVID-19 vaccines against Omicron and Delta hospitalisation, a test negative case-control study
- (2022) Julia Stowe et al. Nature Communications
- Durable spike-specific T-cell responses after different COVID-19 vaccination regimens are not further enhanced by booster vaccination
- (2022) Yacine Maringer et al. Science Immunology
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa
- (2021) Shirley Collie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
- (2021) Katia J Bruxvoort et al. BMJ-British Medical Journal
- Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index
- (2017) Dae Hyun Kim et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
- (2011) H. Quan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started